- Home
- About
- About
- Our Team
- Our Strategies
- Our Strategies
- Worldwide Healthcare
- Emerging Markets Healthcare
- Private Investments
- News
- Contact
- Contact
- Eligible Investors
- Investor Login
English
Chinese (Simplified)
English
- More
- Back
Exome Asset Management is an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices.
The firm practices two existing investment strategies: one which invests broadly across worldwide healthcare subsectors and geographies, and another that is a specialized healthcare investment fund emphasized on public company opportunities in emerging markets.
Exome Asset Management’s investment strategies are broadly diversified by geography and subsector.
Companies dedicated to the discovery, development, production and commercialization of drugs and other medications.
Companies focused on the discovery of new therapeutics, including gene and cell therapy products approaching the market.
Companies that design, manufacture and distribute instruments, consumables, reagents, and various other life science tools and services.
Companies that develop equipment used to prevent, detect, diagnose or treat an illness or disease.
Companies dedicated to facilitating treatment, including by providing care, physical facilities, or the distribution of necessary materials.
Companies involved with various other aspects of the healthcare industry.
Diversity is fundamental to worldwide investing. As such, Exome employs a staff of diverse investment professionals and support staff committed to investing for a healthier world.
Samuel Isaly is Managing Partner and Founder of Exome Asset Management. Mr. Isaly is an experienced healthcare fund manager and has been active in global healthcare investing and analysis for over 45 years.
Over the course of his career, Sam Isaly has been a pharmaceutical analyst with Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S.G. Warburg. In 1989, Mr. Isaly launched OrbiMed Advisors LLC. During his time at OrbiMed, Mr. Isaly was the portfolio manager of Worldwide Healthcare Trust Plc for 22 years.
Mr. Isaly received an A.B. in Economics from Princeton University from which he graduated magna cum laude. Sam was awarded the Percy Allen Ransome Sr. Prize in Economics and was a recipient of the Lieutenant John A. Larkin, Jr., Memorial Scholarship. He was a Fulbright Scholar and attended The London School of Economics where he earned a M. Sc. (Econ.).
Focus Area: Developed and Emerging Markets Healthcare
Contact: IsalyS@exomeasset.com
Wongmo Kang is a Senior Investment Analyst at Exome specializing in emerging markets healthcare. His primary focus is on South Korea and ASEAN healthcare. Prior to joining Exome in 2018, Mr. Kang worked as a strategy consultant at Deloitte & Touché LLP. He also previously served in the United States 8th Army as a sergeant and worked at Mercer LLC. Mr. Kang received a BS/MS in Finance and Accounting from NYU Stern School of Business and is an MBA candidate at Columbia Business School.
Focus Area: Emerging markets healthcare investing, including in Korea, Japan, Singapore, Malaysia, and Thailand
Contact: KangW@exomeasset.com
Yiqi Liu is a Senior Investment Analyst at Exome, covering investment opportunities across all healthcare subsectors in the Greater China region. Prior to joining Exome in 2019, he interned in the investment banking divisions at BNP Paribas and Citi Orient Securities, where he actively participated in several M&A and IPO transactions in the Chinese capital market. Mr. Liu received a B.A. in Economics from Franklin & Marshall College and an M.A. in Economics from Columbia University.
Focus Area: Emerging markets healthcare investing, especially in the Greater China region
Contact: LiuY@exomeasset.com
Sameh Ahsan is a Senior Investment Analyst at Exome Asset. Mr. Ahsan joined Exome in July 2019 following the completion of his undergraduate degree in Economics and a Pre-Health Sciences concentration from New York University. Mr. Ahsan previously worked at Haver Analytics as an Economic Research Assistant and as a science researcher at the University of Oklahoma Health Sciences Center, GI Department.
Focus Area: Emerging markets healthcare investing, including in Latin America, South Africa, India, as well as gene therapy worldwide.
Contact: AhsanS@exomeasset.com
Gary Garofalo joined Exome Asset Management in 2022 as the Head of Trading. Prior to joining Exome, Gary was the Head Trader at Consonance Capital Management, Head Trader at a New York-based Multi Family Office, Managing Director and Head of Trading at Eastwind Global Partners, and the Co-Head Trader at S Squared Technology, a TMT and Healthcare fund. Gary holds a BA from Fordham University.
Brianne Shergill joined Exome Asset Management in 2022 as Head of Compliance and Investor Services. Prior to joining Exome, Brianne was Operations Manager at Consonance Capital Management, where she was involved in the firm’s operations, HR and compliance functions. Brianne holds a BBA from Berkeley College and an MBA from Nyack College.
Joseph Narvaez is the Chief Operating Officer at Exome. Prior to joining Exome in 2018, Mr. Narvaez served as a Network Manager at OrbiMed Advisors LLC, where he managed the firm’s IT systems. Prior to OrbiMed, he was a Systems Analyst at Fidessa Corporation. Mr. Narvaez received his B.S. in Information Technology from the University of Scranton and currently holds a number of industry certifications.
Focus Area: Information Technology (IT) & Accounting
Contact: NarvaezJ@exomeasset.com
Alex Forschner joined Exome in 2020, when the firm converted from a single-family office, and has over seventeen years of investment experience across various financial instruments in both global public and private equity markets. Prior to joining Exome, Mr. Forschner was Senior Managing Director at Maxim Group, where he co-led the firm’s Merchant Capital Division, oversaw $1 billion in deal flow and was responsible for sourcing and structuring multiple equity and debt deals. Mr. Forschner earned his degrees from the University of Arizona.
Jessica Halverson joined Exome Asset Management in 2022. Prior to joining Exome, Jessica was the Property Manager at Fractal Management, a New York City based property management company. Jessica received a B.S. in Communications from East Central University.